IPATF News and Press, ImmunoPrecise Antibodies Ltd. From 03/08/18

LOS ANGELES, CA / ACCESSWIRE / March 8, 2017 / ImmunoPrecise (OTC PINK: IPATF), a full-service, custom, therapeutic antibody discovery CRO, announced that it will be presenting at the inaugural LD Micro Virtual Conference on Thursday, March 8th at 3 PM PST / 6 PM EST. CEO and President, Jenn...

ImmunoPrecise appoints new President and CEO Canada NewsWire VICTORIA, BC, Feb. 8, 2018 VICTORIA, BC , Feb. 8, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company") (TSX VENTURE: IPA)(OTC PINK: IPATF) announces the appointment of Dr. Jennifer Bath , as the new Pre...

ImmunoPrecise Antibodies Grants Stock Options Canada NewsWire VICTORIA, Jan. 27, 2018 VICTORIA , Jan. 27, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company") (TSXV:IPA, Pink Sheets:IPATF) reports that, pursuant to the Company's Stock Option Plan, the Board of Direc...

ImmunoPrecise to strategically invest in foundational Next Generation Antibody Discovery technology Canada NewsWire VICTORIA, Jan. 22, 2018 VICTORIA , Jan. 22, 2018 /CNW/ - IMMUNOPRECISE ANTIBODIES LTD. (the "Company") (TSX VENTURE: IPA)(OTC PINK: IPATF) announces that ...

ImmunoPrecise Engages San Francisco Based LightPath Capital as a Key Partner in its Financing Strategy Canada NewsWire VICTORIA, BC, Jan. 18, 2018 VICTORIA, BC , Jan. 18, 2018 /CNW/ -  IMMUNOPRECISE ANTIBODIES LTD. (the "Company") (TSX VENTURE: IPA)(OTC PINK: IPATF)...